Skip to content

A Study to Evaluate the Effectiveness and Safety of an Implant in the Treatment of Osteoarthritis of the Great Toe

A Study to Evaluate the Effectiveness and Safety of an Implant in the Treatment of Osteoarthritis of the Great Toe

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00969969
Enrollment
236
Registered
2009-09-02
Start date
2009-08-31
Completion date
2016-07-31
Last updated
2016-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of First Metatarsalphalangeal Joint

Keywords

First MTP Joint, Hallux Rigidus, Hallux Limitus, Cartilage Replacement, Osteoarthritis, First MTP Joint Osteoarthritis, Big Toe Pain

Brief summary

This study will evaluate whether Cartiva is an effective treatment for individuals with osteoarthritis of the great toe.

Interventions

DEVICEArthrodesis

arthrodesis using screws and/or a plate

DEVICECartiva

Cartiva Synthetic Cartilage Implant

Sponsors

Cartiva, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years of age * Osteoarthritis of the first metatarsophalangeal joint and is a candidate for arthrodesis * Presence of good bone stock * Capable of completing self-administered questionnaires

Exclusion criteria

* \< 18 years of age * Osteoarthritis of the first metatarsophalangeal joint, though is not a candidate for arthrodesis * Active bacterial infection of the foot * Additional ipsilateral limb (hip, knee, ankle, or foot) pathology that requires active treatment (surgery or brace)

Design outcomes

Primary

MeasureTime frameDescription
VAS, FAAM, Safetyup to 2 yearsThe individual components of the primary outcome measures will be Visual Analog Scale (VAS) Pain, Foot and Ankle Ability Measure (FAAM) Sports sub-scale score and absence of key safety issues.

Countries

Canada, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026